SEC Form 4 · accession 0002115339-26-000004
Sana Biotechnology, Inc. · SANA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dhavalkumar Dhirajlal Patel
Officer — EVP, Chief Scientific Officer
Period of report
Aug 26, 2026
Accepted (ET)
Aug 27, 2026 · 4:21 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001770121
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 26, 2026 | M | 125,000 | $0.00 | A | 224,510 | D | |
| Common Stock | Aug 27, 2026 | F | 41,158 | $4.11 | D | 183,352 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Aug 26, 2026 | M | 125,000 | D | — | — | Common Stock | 125,000 | 250,000 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Sana Biotechology, Inc. ("Sana") common stock.
- F2The award vested as to 25% of the restricted stock units on each of August 26, 2025 and 2026, and the remaining restricted stock units will vest in two equal installments on each of August 26, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date.